2 unchanged sentences
Description of Exhibit
+Added: Form of Series A Warrant (incorporated by reference to the Company's Current Report on Form 8-K filed with the SEC on July 25, 2022).
+Added: Form of Series B Warrant (incorporated by reference to the Company's Current Report on Form 8-K filed with the SEC on July 25, 2022).
+Added: Form of Pre-Funded Warrant (incorporated by reference to the Company's Current Report on Form 8-K filed with the SEC on July 25, 2022).
+Added: Form of Placement Agent Warrant (incorporated by reference to the Company's Current Report on Form 8-K filed with the SEC on July 25, 2022).
+Added: Form of Securities Purchase Agreement, dated as of July 25, 2022, by and among the Company and the purchasers party thereto (incorporated by reference to the Company's Current Report on Form 8-K filed with the SEC on July 25, 2022).
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
14 unchanged sentences
Acurx Pharmaceuticals, Inc.
−Removed: August 12, 2022
+Added: November 10, 2022
President and Chief Executive Officer
(Principal Executive Officer)
−Removed: August 12, 2022
+Added: November 10, 2022
/s/ Robert G.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.